It is estimated that symptoms of attention deficit/hyperactivity disorder (ADHD) persist into adulthood in 50% to 60% of those diagnosed with the condition in childhood and adolescence. According to researchers, more than eight million adults in the United States have ADHD .
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.